fda warning letters bpc-157 2023 to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters Content Analysis of US FDA

Yes, based on vial mass

(4) Blood Pressure (3) In blood pressure studies, compared with l-arginine, pentadecapeptide BPC 157 (without effect on basal normal values) had both a mimicking effect (impaired l-NAME-blood pressure increase, when applied prophylactically and decreased already raised l-NAME values, given at the time of the maximal l-NAME-blood pressure increase (i.e., 10 min after l-NAME)) and preventive activity (l-arginine-induced moderate blood pressure decrease was prevented by BPC 157 pretreatment)

By contrast, the individuals with Alzheimer's registered by MCBS are likely to be those with more severe, and therefore more costly, illness

Neurologic manifestations will not be prevented with folic acid, and if not treated with Vitamin B12, irreversible damage will result